Seattle, Wa. 98104,USA
+1.415.238.4161
heidiurnesslaw@gmail.com

Category: Marijuana

Top Powerful Cannabis Attorney You Should Know

Slew of Lawsuits Highlight CBD Labeling and Advertising Risks

By: Heidi Urness, Attorney at Heidi Urness Law, PLLC 2019, as predicted, was the “Year of CBD.” Fueled by the passage of the 2018 Farm Bill, CBD and other hemp-derived products, as well as ancillary businesses, exploded into the marketplace. However, as reputable companies began marketing and selling to consumers all over the country, less…
Read more

Roadside Drug Testing Expands with Help of New Technologies

By: Heidi Urness, Attorney at Heidi Urness Law One of the key policy concerns regarding the federal legalization of cannabis centers on the public safety risk of drugged drivers. Not only do scientists and lawmakers disagree about the legally determined limit to which THC found in blood, breath, or saliva would constitute impairment, but to…
Read more

Did Washington State Just Ban CBD from All Food and Drink Products?

By: Heidi Urness, Attorney at Heidi Urness Law Earlier this month (August 2019), the Washington State Department of Agriculture (“WSDA”) released a statement regarding the use of CBD as a food ingredient, which some reported as an act by the state to suddenly “ban all CBD-infused food and drinks.” However, the WSDA has never permitted…
Read more

Sour Patch Kids v. Stoney Patch: Dilution, Tarnishment, and Marijuana Trademark Litigation

By: Heidi Urness, Attorney at Heidi Urness Law Last month (July 2019), the manufacturer of the popular candy Sour Patch Kids (Mondelëz Canada Inc., or “MCI”) filed a trademark lawsuit against the makers of “Stoney Patch” Sour & Sweet Jelly Candies – which are THC-infused gummies – in federal court. While information regarding the lawsuit…
Read more

Legalize Marijuana, Decrease Teen Marijuana Use

By: Heidi Urness, Attorney at Heidi Urness Law Last month (July 2019), JAMA Pediatrics, a monthly peer-reviewed medical journal published by the American Medical Association and covers all aspects of the science of child and adolescent health, published an article providing insights into correlations between permissive marijuana laws and teen marijuana use. While many news…
Read more

Heidi Urness is Literally Defining Legal Cannabis

By: Mitch Pfeifer  Published in: Respect My Region, May 2019 Heidi Urness is one of the rising stars in the industry. [Cannabis attorneys] have seen tomato farmers grow into full-fledged cannabis entrepreneurs. In this same way, Urness had made the transition from environmental law to helping shape the landscape for legal cannabis in Washington State.…
Read more

One Nation, Under Hemp: The 2018 Farm Bill

By: Heidi Urness, Attorney at Heidi Urness Law The 2018 Farm Bill was signed into law just before the turn of the new year, causing a great stir in the cannabis community. While the 2018 Farm Bill does not affect Federal laws with respect to marijuana, its passage is monumental for the hemp industry: For the first time, Congress…
Read more

Heidi Urness Nationally Recognized as “Top 30 Powerful Cannabis Attorney”

Published in: mg Magazine, November 2018 Broadly defined, litigation is the process of resolving a dispute between opposing parties through the court system. In business, any relationship–with vendors, suppliers, employees, customers, or competitors–is subject to misunderstanding and miscommunication that can result in litigation. In the burgeoning legal cannabis industry, the opportunity for such occurrences is…
Read more

Conflicts in Interstate Transportation of Hemp and CBD

By: Heidi Urness, Attorney at Heidi Urness Law The hemp and hemp-derived CBD industries currently face enormous legal uncertainty. Many clients have questions with regard to the marketing, sale, and transportation of hemp across state lines. Unfortunately, the authorities that define the rights, responsibilities, and liabilities that apply to the hemp industry are currently in conflict, and…
Read more

Some CBD Products Rescheduled by DEA Under Controlled Substances Act

By: Heidi Urness, Attorney at Heidi Urness Law The Drug Enforcement Administration (DEA) announced last Friday that certain Food and Drug Administration (FDA)-approved drugs that contain cannabidiol (CBD) are properly rescheduled as Schedule V drugs under the Controlled Substances Act (CSA). While this move is far from categorically rescheduling CBD – as only specific drugs will be placed on…
Read more